On a rainy Monday morning, 58-year-old Annet Nalubwama stood in a long line on the grounds of the Mukono district, waiting to get her first Covid-19 vaccination.
At 8 a.m., By the time the vaccination exercise was to begin, hundreds of people had filled the grounds during a morning drizzle after the government announced it would run a third Covid-19 vaccination campaign.
Ms. Nalubwama, who had one three months earlier Sister had lost to Covid-19, had decided to take the vaccination under pressure from her daughters.
“I didn’t want to take the vaccine, but I want me and my family to be safe, we want our normal life back and if a vaccination is needed then we have to do it, ”she said.
Ms. Nalubwama is just one of thousands of Ugandans across the country who have had Covid- 19 are urging vaccination centers to vaccinate themselves as US continues There is certainty when the country will secure enough vaccine doses in connection with lockdown fatigue.
About 15 km away in Ka mpala at the Mutungo Parents Vaccination Center, hundreds of people stood in line and sat on benches, waiting to be heard by health officials to be looked after.
Joel Mukisa, 32, had arrived earlier than the prescribed time for the vaccination. It was his second attempt in as many days.
“If you start early, you have a better chance of getting vaccinated. I was here at 6:30 am just to find so many others who came earlier than me, ”he said.
The scenes in Mukono and Kampala have been replicated across the country.
The current vaccination campaign is taking place against the backdrop of a vicious second wave, mainly the Delta variant, which sent the country into a second 42-day total lockdown, distorting livelihoods and further burdening the economy .
As of last Thursday, the cumulative number of coronavirus cases in Uganda was 123,445 and 3,152 deaths.
According to health officials, the higher vaccination rate from lockdown fatigue could have fatal effects from the last one Wave and the ongoing awareness.
Emmanuel Ainebyoona, spokesman for the Ministry of Health, told The EastAfrican that the demand for vaccination is high due to the availability of a significant number of different types of doses.
“Several people stayed away because they were waiting to find a certain Va. to take ccine for example Pfizer. Now that these types of vaccines are available, people are coming to get vaccinated, “said Mr Ainebyoona.
The National Medicines Agency has already approved six emergency vaccines . The approved vaccines are AstraZeneca, Janssen, Pfizer / BionTech, Sinovac, Sinopharm, Sputnik V, Sputnik Lite and Moderna.
So far, Uganda has received donations from the vaccines AstraZeneca, Pfizer and Sinovac.
Minister of State for Primary Health Care Margaret Muhanga said that to date 5,129,763 doses of various types of vaccines have been received through donations, of which 2,200,321 doses have been used.
Reliance on donations has raised questions about what if the current number of people crowding into vaccination centers use up the few remaining doses before adding more.
Also, the reopening of schools aims to vaccinate learners, thereby reducing the number of Vaccinations could rise to five million, which is a far cry from the targeted 22 million people.
For this fiscal year, the government has given the National Medical Stores (NMS) about $ 2 million to purchase provided by vaccines.
According to NMS, the money has already been used to book additional vaccines. It will be in the country soon, although a date has not yet been announced.
The country has over the Covax facility ordered nine million doses of the AstraZeneca vaccines. In addition, the company has placed an order for two million Johnson & Johnson vaccines through the African Union for a $ 3 million deposit.
Ainebyoona said it was using the first batch of Johnson & Johnson vaccines 196,800 doses will arrive this week.
The availability of this particular vaccine, which is cheap for children, will determine when schools open.
In several of his speeches to the nation President Yoweri Museveni advised that in the case of the Johnson & Johnson vaccine, priority will be given to students whose academic calendar has been disrupted for two years.